Get started

Longeveron Inc

NASDAQLGVN
At close
No trades
See on super-charts
Overview
News Ideas Financials Technicals Forecast

LGVN chart

Key stats

Market capitalization
56.77MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.90USD

About Longeveron Inc

ISIN
US54303L1044
Sector
Health Technology
Industry
Biotechnology
Website
longeveron.com
CEO
Wa'el Hashad
Headquarters
Miami
Employees
19
Founded
2014

Longeveron, Inc. is a clinical stage biotechnology company. It engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffers on October 9, 2014 and is headquartered in Miami, FL.

Ideas

LGVN Fish Hook PatternNASDAQ:LGVN The clinical stage biotechnology company developing cellular therapies for life-threatening conditions, Longeveron Inc. (NASDAQ: LGVN) has been regaining some of the momentum it lost following its 128% surge. Considering that its Alzheimer's treatment showed impressive results in its ph
1
$LGVN – SI 65%Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are s
Long
the trend is your friend ↘︎lvgn being held back by its top trendline resistance and in a nasty downtrend. I have seen this pattern too many times, 1-2 days of crazy upside, traps longs and then it never comes back to highs. my price targets are 9.29-6.08-3.25 be careful if long here, and goodluck! like and follow for more
4
$LGVN entry PT 25 Target PTs 43-49 and higherLongeveron stock is up by a multiple of 11 after the FDA gave a Rare Pediatric Disease designation for a heart medication last week. Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company's lea
Long
1
LGVN - Due for a retracement?It seems like everybody is bullish on this - for obvious reasons short-term - but I feel like there might a move for the imbalances around the $23 and $18 levels. No idea what it might do at these levels but I do suspect a move down to them in the coming hours/days.
2

See all ideas 

News flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
‪0‬
Revenue
‪0‬

Gain new superpowers

Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world.Learn more